A new trading day began on Monday, with Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) stock price up 1.69% from the previous day of trading, before settling in for the closing price of $17.77. TEVA’s price has ranged from $12.47 to $22.80 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -0.43% over the last five years. Meanwhile, its annual earnings per share averaged 1.95%. With a float of $1.15 billion, this company’s outstanding shares have now reached $1.15 billion.
The firm has a total of 36167 workers. Let’s measure their productivity. In terms of profitability, gross margin is 49.16%, operating margin of 7.54%, and the pretax margin is -3.15%.
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Teva- Pharmaceutical Industries Ltd. ADR is 0.01%, while institutional ownership is 62.95%. The most recent insider transaction that took place on Jun 03 ’25, was worth 105,628. In this transaction EVP, Global Operations of this company sold 6,206 shares at a rate of $17.02, taking the stock ownership to the 9,989 shares. Before that another transaction happened on Jun 03 ’25, when Company’s Officer proposed sale 6,206 for $17.02, making the entire transaction worth $105,628.
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.72 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 1.95% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.35% during the next five years compared to -9.62% drop over the previous five years of trading.
Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) Trading Performance Indicators
Here are Teva- Pharmaceutical Industries Ltd. ADR’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.74. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.25. Likewise, its price to free cash flow for the trailing twelve months is 9.94.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.14, a number that is poised to hit 0.64 in the next quarter and is forecasted to reach 2.74 in one year’s time.
Technical Analysis of Teva- Pharmaceutical Industries Ltd. ADR (TEVA)
Analysing the last 5-days average volume posted by the [Teva- Pharmaceutical Industries Ltd. ADR, TEVA], we can find that recorded value of 10.59 million was lower than the volume posted last year of 12.5 million. As of the previous 9 days, the stock’s Stochastic %D was 66.95%. Additionally, its Average True Range was 0.65.
During the past 100 days, Teva- Pharmaceutical Industries Ltd. ADR’s (TEVA) raw stochastic average was set at 56.42%, which indicates a significant decrease from 88.92% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 39.82% in the past 14 days, which was lower than the 51.61% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $15.84, while its 200-day Moving Average is $17.52. Now, the first resistance to watch is $18.18. This is followed by the second major resistance level at $18.29. The third major resistance level sits at $18.50. If the price goes on to break the first support level at $17.87, it is likely to go to the next support level at $17.66. Now, if the price goes above the second support level, the third support stands at $17.55.
Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) Key Stats
With a market capitalization of 20.71 billion, the company has a total of 1,146,960K Shares Outstanding. Currently, annual sales are 16,544 M while annual income is -1,639 M. The company’s previous quarter sales were 3,891 M while its latest quarter income was 214,000 K.
